228
Views
24
CrossRef citations to date
0
Altmetric
Gastrointestinal hormones

Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion

, , , , , , & show all
Pages 428-435 | Received 12 Aug 2010, Accepted 28 Oct 2010, Published online: 30 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anne-Barbara Witte, Linda Hilsted, Jens Juul Holst & Peter Thelin Schmidt. (2016) Peptide YY3-36 and glucagon-like peptide-1 in functional dyspepsia. Secretion and role in symptom generation. Scandinavian Journal of Gastroenterology 51:4, pages 400-409.
Read now
Kristian Bjøro. (2011) This Month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:4, pages 387-388.
Read now

Articles from other publishers (22)

Kazuyuki Takahashi, Hiroki Fujita, Naoko Fujita, Yuya Takahashi, Shunsuke Kato, Tatsunori Shimizu, Yumi Suganuma, Takehiro Sato, Hironori Waki & Yuichiro Yamada. (2022) A Pilot Study to Assess Glucose, Insulin, and Incretin Responses Following Novel High Resistant Starch Rice Ingestion in Healthy Men. Diabetes Therapy 13:7, pages 1383-1393.
Crossref
Lærke Smidt Gasbjerg, Emilie Johanning Bari, Mikkel Christensen & Filip Krag Knop. (2021) Exendin(9‐39) NH 2 : Recommendations for clinical use based on a systematic literature review . Diabetes, Obesity and Metabolism 23:11, pages 2419-2436.
Crossref
Youngmi Song, Jacqueline A. Koehler, Laurie L. Baggio, Alvin C. Powers, Darleen A. Sandoval & Daniel J. Drucker. (2019) Gut-Proglucagon-Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice. Cell Metabolism 30:5, pages 976-986.e3.
Crossref
Jukkrapong Pinyo, Tohru Hira & Hiroshi Hara. (2019) Enhanced postprandial glucagon-like peptide-1 secretion during obesity development has a protective role against glucose intolerance induction in rats. British Journal of Nutrition 122:04, pages 411-422.
Crossref
Alexander T. May, Molly S. Crowe, Bryan A. Blakeney, Sunila Mahavadi, Hongxia Wang, John R. Grider & Karnam S. Murthy. (2019) Identification of expression and function of the glucagon-like peptide-1 receptor in colonic smooth muscle. Peptides 112, pages 48-55.
Crossref
Louise Lang Lehrskov, Mark Preben Lyngbaek, Line Soederlund, Grit Elster Legaard, Jan Adam Ehses, Sarah Elizabeth Heywood, Nicolai Jacob Wewer Albrechtsen, Jens Juul Holst, Kristian Karstoft, Bente Klarlund Pedersen & Helga Ellingsgaard. (2018) Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control. Cell Metabolism 27:6, pages 1201-1211.e3.
Crossref
Yanqing Zhang, Meifen Wu, Wynn Htun, Emily W. Dong, Franck Mauvais-Jarvis, Vivian A. Fonseca & Hongju Wu. (2017) Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors. Scientific Reports 7:1.
Crossref
Tongzhi Wu, Christopher K Rayner & Michael Horowitz. (2016) Inter-regulation of gastric emptying and incretin hormone secretion: implications for postprandial glycemic control. Biomarkers in Medicine 10:11, pages 1167-1179.
Crossref
Palash Kar, Mark P. Plummer, Marianne J. Chapman, Caroline E. Cousins, Kylie Lange, Michael Horowitz, Karen L. Jones & Adam M. Deane. (2016) Energy-Dense Formulae May Slow Gastric Emptying in the Critically Ill. Journal of Parenteral and Enteral Nutrition 40:7, pages 1050-1056.
Crossref
Mark M Smits, Daniel H van Raalte, Lennart Tonneijck, Marcel H A Muskiet, Mark H H Kramer & Djuna L Cahen. (2016) GLP-1 based therapies: clinical implications for gastroenterologists. Gut 65:4, pages 702-711.
Crossref
M. M. Smits, L. Tonneijck, M. H. A. Muskiet, M. H. H. Kramer, D. L. Cahen & D. H. van Raalte. (2016) Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas. Diabetes, Obesity and Metabolism 18:3, pages 224-235.
Crossref
Jutta Keller, Ulrich Binnewies, Marie Rösch, Jens Juul Holst, Christoph Beglinger, Viola Andresen & Peter Layer. (2015) Gastric emptying and disease activity in inflammatory bowel disease. European Journal of Clinical Investigation 45:12, pages 1234-1242.
Crossref
Tongzhi Wu, Christopher K. Rayner & Michael Horowitz. 2016. Metabolic Control. Metabolic Control 137 171 .
Thomas J. O'Malley, Genevieve E. Fava, Yanqing Zhang, Vivian A. Fonseca & Hongju Wu. (2014) Progressive change of intra-islet GLP-1 production during diabetes development. Diabetes/Metabolism Research and Reviews 30:8, pages 661-668.
Crossref
Tongzhi Wu, Christopher K Rayner, Richard L Young & Michael Horowitz. (2013) Gut motility and enteroendocrine secretion. Current Opinion in Pharmacology 13:6, pages 928-934.
Crossref
Amanda Jiménez, Roser Casamitjana, Judith Viaplana-Masclans, Antonio Lacy & Josep Vidal. (2013) GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery. Diabetes Care 36:7, pages 2062-2069.
Crossref
Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones & Michael Horowitz. (2013) Glucagon-like peptides 1 and 2 in health and disease: A review. Peptides 44, pages 75-86.
Crossref
Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones & Michael Horowitz. (2013) Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones. Diabetes Care 36:5, pages 1396-1405.
Crossref
J. E. Stevens, M. Horowitz, C. F. Deacon, M. Nauck, C. K. Rayner & K. L. Jones. (2012) The effects of sitagliptin on gastric emptying in healthy humans – a randomised, controlled study. Alimentary Pharmacology & Therapeutics 36:4, pages 379-390.
Crossref
Jonathan D Roth, Mary R Erickson, Steve Chen & David G Parkes. (2012) GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities. British Journal of Pharmacology 166:1, pages 121-136.
Crossref
Omotayo O. Erejuwa, Siti A. Sulaiman & Mohd S. Ab Wahab. (2011) Oligosaccharides Might Contribute to the Antidiabetic Effect of Honey: A Review of the Literature. Molecules 17:1, pages 248-266.
Crossref
Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones & Michael Horowitz. (2011) Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function. Experimental Diabetes Research 2011, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.